@article{JTD20790,
author = {Lorenza Landi and Antonio Rossi},
title = {Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 17},
year = {2018},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) is divided in two main histologies: non-squamous and squamous histotypes. In metastatic non-squamous NSCLC patients, the oncogene-addicted subgroups are characterized by the presence of epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) and proto-oncogene tyrosine-protein kinase 1 (ROS1) deregulations which can benefit, in the current practice, by specific tyrosine kinase inhibitors (TKIs).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/20790}
}